Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Non-Hodgkin Lymphoma

Clinical trial condition

Refractory Non-Hodgkin Lymphoma

Explore clinical trials studying Refractory Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

54 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Refractory Non-Hodgkin Lymphoma trial results

Active, Not Recruiting

Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma

NCT01703949

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

NCT03479268

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
Locations: City of Hope Medical Center Duarte, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions: Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Arizona Oncology Associates Tucson, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

University of California Irvine Health Orange, California, United States

View all 66 locations

View Trial Details

Active, Not Recruiting

Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma

NCT05621096

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +17 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details